A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned

[1]  H. Hallander,et al.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.

[2]  D Greco,et al.  A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. , 1996, The New England journal of medicine.

[3]  G. Poland.  Acellular pertussis vaccines: new vaccines for an old disease , 1996, The Lancet.

[4]  M. Gahr,et al.  Efficacy of acellular pertussis vaccine in early childhood after household exposure. , 1996, JAMA.

[5]  W. Blackwelder,et al.  A placebo-controlled trial of a pertussis-toxoid vaccine. , 1995, The New England journal of medicine.

[6]  M. Pichichero,et al.  A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines. , 1995, Pediatrics.

[7]  S. Szu,et al.  Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. , 1995, The Journal of infectious diseases.

[8]  N. Andrews,et al.  Diphtheria immunity in UK blood donors , 1995, The Lancet.

[9]  J. Taranger,et al.  Parapertussis infection followed by pertussis infection , 1994, The Lancet.

[10]  M. Pittman,et al.  Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine , 1993, The Pediatric infectious disease journal.

[11]  M. Granström,et al.  Serological correlates in whooping cough. , 1993, Vaccine.

[12]  I. Onorato,et al.  Efficacy of whole-cell pertussis vaccine in preschool children in the United States. , 1992, JAMA.

[13]  M. Granström,et al.  Specific immunoglobulin for treatment of whooping cough , 1991, The Lancet.

[14]  W. Blackwelder,et al.  Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. , 1991, American journal of diseases of children.

[15]  C. Farrington,et al.  Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. , 1990, Vaccine.

[16]  J. Taranger,et al.  History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. , 1990, The Journal of pediatrics.

[17]  Adhocgroupforthestudyofpert.  PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN?PROTECIVE EFFICACY AND ADVERSE EVENTS , 1988 .

[18]  D. Jenkinson.  Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study , 1988, British medical journal.

[19]  P. Fine,et al.  Reflections on the efficacy of pertussis vaccines. , 1987, Reviews of infectious diseases.

[20]  M. Granström,et al.  Neutralizing antibodies to pertussis toxin in whooping cough. , 1985, The Journal of infectious diseases.

[21]  Yuji Sato,et al.  Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system , 1984, Infection and immunity.

[22]  B. Meade,et al.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor , 1984, Infection and immunity.

[23]  P. Grob,et al.  Effect of vaccination on severity and dissemination of whooping cough. , 1981, British medical journal.

[24]  M. Pittman.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. , 1979, Reviews of infectious diseases.

[25]  J. Nelson.  The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. , 1978, American journal of diseases of children.

[26]  P. Kendrick.  Can whooping cough be eradicated? , 1975, The Journal of infectious diseases.

[27]  J. W. Smith.  [Diphtheria and tetanus toxoids]. , 1969, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

[28]  S. I. Morse.  Pertussis in adults. , 1968, Annals of internal medicine.

[29]  R. M. Atwater.  Prevention of Whooping-cough by Vaccination , 1951, British medical journal.

[30]  J. Ipsen,et al.  Circulating antitoxin at the onset of diphtheria in 425 patients. , 1946, Journal of immunology.

[31]  R. Gibbons.  Diphtheria among Schick-Negative Persons in Halifax, Nova Scotia. , 1945 .

[32]  J. Warin.  Schick Immunity after Active Immunization compared with that following Diphtheria , 1940, British medical journal.